243 related articles for article (PubMed ID: 28659615)
41. Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor.
Choi JH; Ji YG; Lee DH
Pancreas; 2013 May; 42(4):680-6. PubMed ID: 23462325
[TBL] [Abstract][Full Text] [Related]
42. Protein histidine phosphatase 1 negatively regulates CD4 T cells by inhibiting the K+ channel KCa3.1.
Srivastava S; Zhdanova O; Di L; Li Z; Albaqumi M; Wulff H; Skolnik EY
Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14442-6. PubMed ID: 18796614
[TBL] [Abstract][Full Text] [Related]
43. Immature human dendritic cells enhance their migration through KCa3.1 channel activation.
Crottès D; Félix R; Meley D; Chadet S; Herr F; Audiger C; Soriani O; Vandier C; Roger S; Angoulvant D; Velge-Roussel F
Cell Calcium; 2016 Apr; 59(4):198-207. PubMed ID: 27020659
[TBL] [Abstract][Full Text] [Related]
44. P2Y2 receptor activation opens pannexin-1 channels in rat carotid body type II cells: potential role in amplifying the neurotransmitter ATP.
Zhang M; Piskuric NA; Vollmer C; Nurse CA
J Physiol; 2012 Sep; 590(17):4335-50. PubMed ID: 22733659
[TBL] [Abstract][Full Text] [Related]
45. Double-modified, thio and methylene ATP analogue facilitates wound healing in vitro and in vivo.
Pawlowska R; Radzikowska-Cieciura E; Jafari S; Fastyn J; Korkus E; Gendaszewska-Darmach E; Zhao G; Snaar-Jagalska E; Chworos A
Sci Rep; 2024 Jun; 14(1):13148. PubMed ID: 38849425
[TBL] [Abstract][Full Text] [Related]
46. Purinergic signalling mediates bidirectional crosstalk between chemoreceptor type I and glial-like type II cells of the rat carotid body.
Murali S; Nurse CA
J Physiol; 2016 Jan; 594(2):391-406. PubMed ID: 26537220
[TBL] [Abstract][Full Text] [Related]
47. P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.
Bowler JW; Bailey RJ; North RA; Surprenant A
Br J Pharmacol; 2003 Oct; 140(3):567-75. PubMed ID: 12970084
[TBL] [Abstract][Full Text] [Related]
48.
Olotu C; Lehmensiek F; Koch B; Kiefmann M; Riegel AK; Hammerschmidt S; Kiefmann R
J Biol Chem; 2019 Aug; 294(34):12795-12806. PubMed ID: 31289122
[TBL] [Abstract][Full Text] [Related]
49. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
50. High-affinity P2Y2 and low-affinity P2X7 receptor interaction modulates ATP-mediated calcium signaling in murine osteoblasts.
Mikolajewicz N; Smith D; Komarova SV; Khadra A
PLoS Comput Biol; 2021 Jun; 17(6):e1008872. PubMed ID: 34153025
[TBL] [Abstract][Full Text] [Related]
51. The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.
Henríquez C; Riquelme TT; Vera D; Julio-Kalajzić F; Ehrenfeld P; Melvin JE; Figueroa CD; Sarmiento J; Flores CA
Acta Physiol (Oxf); 2016 Jan; 216(1):132-45. PubMed ID: 26138196
[TBL] [Abstract][Full Text] [Related]
52. Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo.
Bachmann M; Rossa A; Varanita T; Fioretti B; Biasutto L; Milenkovic S; Checchetto V; Peruzzo R; Ahmad SA; Patel SH; Lukowski R; Edwards MJ; Ceccarelli M; Gulbins E; Zoratti M; Mattarei A; Szabo I
Cell Death Dis; 2022 Dec; 13(12):1055. PubMed ID: 36539400
[TBL] [Abstract][Full Text] [Related]
53. ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells.
Zhang JL; Liu Y; Yang H; Zhang HQ; Tian XX; Fang WG
Cancer Sci; 2017 Jul; 108(7):1318-1327. PubMed ID: 28474758
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
55. KCa3.1 Channels and Glioblastoma: In Vitro Studies.
Klumpp L; Sezgin EC; Skardelly M; Eckert F; Huber SM
Curr Neuropharmacol; 2018; 16(5):627-635. PubMed ID: 28786347
[TBL] [Abstract][Full Text] [Related]
56. Downregulation of the Ca
Kito H; Morihiro H; Sakakibara Y; Endo K; Kajikuri J; Suzuki T; Ohya S
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C345-C358. PubMed ID: 32520608
[TBL] [Abstract][Full Text] [Related]
57. Investigating CFTR and KCa3.1 Protein/Protein Interactions.
Klein H; Abu-Arish A; Trinh NT; Luo Y; Wiseman PW; Hanrahan JW; Brochiero E; Sauvé R
PLoS One; 2016; 11(4):e0153665. PubMed ID: 27092946
[TBL] [Abstract][Full Text] [Related]
58. Characterisation of large-conductance calcium-activated potassium channels (BK(Ca)) in human NT2-N cells.
Chapman H; Piggot C; Andrews PW; Wann KT
Brain Res; 2007 Jan; 1129(1):15-25. PubMed ID: 17156763
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca
Matsui M; Kajikuri J; Kito H; Endo K; Hasegawa Y; Murate S; Ohya S
Mol Pharmacol; 2019 Mar; 95(3):294-302. PubMed ID: 30622214
[TBL] [Abstract][Full Text] [Related]
60. Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines.
Katzur AC; Koshimizu T; Tomić M; Schultze-Mosgau A; Ortmann O; Stojilkovic SS
J Clin Endocrinol Metab; 1999 Nov; 84(11):4085-91. PubMed ID: 10566654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
